154 related articles for article (PubMed ID: 27009842)
21. ATRX binds to atypical chromatin domains at the 3' exons of zinc finger genes to preserve H3K9me3 enrichment.
Valle-García D; Qadeer ZA; McHugh DS; Ghiraldini FG; Chowdhury AH; Hasson D; Dyer MA; Recillas-Targa F; Bernstein E
Epigenetics; 2016 Jun; 11(6):398-414. PubMed ID: 27029610
[TBL] [Abstract][Full Text] [Related]
22. Retinoic Acid for High-risk Neuroblastoma Patients after Autologous Stem Cell Transplantation - Cochrane Review.
Peinemann F; van Dalen EC; Berthold F
Klin Padiatr; 2016 Apr; 228(3):124-9. PubMed ID: 27011226
[TBL] [Abstract][Full Text] [Related]
23. Whole exome sequencing of urachal adenocarcinoma reveals recurrent NF1 mutations.
Singh H; Liu Y; Xiao X; Lin L; Kim J; Van Hummelen P; Wu CL; Bass AJ; Saylor PJ
Oncotarget; 2016 May; 7(20):29211-5. PubMed ID: 27078850
[TBL] [Abstract][Full Text] [Related]
24. Genetic susceptibility to neuroblastoma.
Tolbert VP; Coggins GE; Maris JM
Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
[TBL] [Abstract][Full Text] [Related]
25. Proteomic Alterations in Response to Hypoxia Inducible Factor 2α in Normoxic Neuroblastoma Cells.
Cimmino F; Pezone L; Avitabile M; Persano L; Vitale M; Sassi M; Bresolin S; Serafin V; Zambrano N; Scaloni A; Basso G; Iolascon A; Capasso M
J Proteome Res; 2016 Oct; 15(10):3643-3655. PubMed ID: 27596920
[TBL] [Abstract][Full Text] [Related]
26. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma.
Capasso M; Lasorsa VA; Cimmino F; Avitabile M; Cantalupo S; Montella A; De Angelis B; Morini M; de Torres C; Castellano A; Locatelli F; Iolascon A
Cancer Res; 2020 Feb; 80(3):382-393. PubMed ID: 31784426
[TBL] [Abstract][Full Text] [Related]
27. Somatic mutations in specific and connected subpathways are associated with short neuroblastoma patients' survival and indicate proteins targetable at onset of disease.
Esposito MR; Binatti A; Pantile M; Coppe A; Mazzocco K; Longo L; Capasso M; Lasorsa VA; Luksch R; Bortoluzzi S; Tonini GP
Int J Cancer; 2018 Nov; 143(10):2525-2536. PubMed ID: 29992558
[TBL] [Abstract][Full Text] [Related]
28. Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
Fransson S; Martinez-Monleon A; Johansson M; Sjöberg RM; Björklund C; Ljungman G; Ek T; Kogner P; Martinsson T
Sci Rep; 2020 Dec; 10(1):22432. PubMed ID: 33384420
[TBL] [Abstract][Full Text] [Related]
29. Genetic Predisposition to Solid Pediatric Cancers.
Capasso M; Montella A; Tirelli M; Maiorino T; Cantalupo S; Iolascon A
Front Oncol; 2020; 10():590033. PubMed ID: 33194750
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the c.793-1G > A splicing variant in CHEK2 gene as pathogenic: a case report.
Agiannitopoulos K; Papadopoulou E; Tsaousis GN; Pepe G; Kampouri S; Kocdor MA; Nasioulas G
BMC Med Genet; 2019 Jul; 20(1):131. PubMed ID: 31349801
[TBL] [Abstract][Full Text] [Related]
31. Research progress of neuroblastoma related gene variations.
Cao Y; Jin Y; Yu J; Wang J; Yan J; Zhao Q
Oncotarget; 2017 Mar; 8(11):18444-18455. PubMed ID: 28055978
[TBL] [Abstract][Full Text] [Related]
32. Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani NL; Dymek M; Desai H; Hausler R; Hicks B; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
J Natl Cancer Inst; 2024 Jan; 116(1):149-159. PubMed ID: 37688579
[TBL] [Abstract][Full Text] [Related]
33. BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma.
Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
J Natl Cancer Inst; 2024 Jan; 116(1):138-148. PubMed ID: 37688570
[TBL] [Abstract][Full Text] [Related]
34. Clinical Response to a PARP Inhibitor and Chemotherapy in a Child with BARD1-Mutated Refractory Neuroblastoma: A Case Report.
Cupit-Link M; Hagiwara K; Zhang J; Federico SM
Res Sq; 2023 Aug; ():. PubMed ID: 37645774
[TBL] [Abstract][Full Text] [Related]
35. Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
Hanson H; Astiazaran-Symonds E; Amendola LM; Balmaña J; Foulkes WD; James P; Klugman S; Ngeow J; Schmutzler R; Voian N; Wick MJ; Pal T; Tischkowitz M; Stewart DR;
Genet Med; 2023 Oct; 25(10):100870. PubMed ID: 37490054
[TBL] [Abstract][Full Text] [Related]
36.
Abdelghani E; Schieffer KM; Cottrell CE; Audino A; Zajo K; Shah N
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980535
[TBL] [Abstract][Full Text] [Related]
37.
Randall MP; Egolf LE; Vaksman Z; Samanta M; Tsang M; Groff D; Evans JP; Rokita JL; Layeghifard M; Shlien A; Maris JM; Diskin SJ; Bosse KR
bioRxiv; 2023 Feb; ():. PubMed ID: 36778420
[TBL] [Abstract][Full Text] [Related]
38. Germline pathogenic variants in 786 neuroblastoma patients.
Kim J; Vaksman Z; Egolf LE; Kaufman R; Evans JP; Conkrite KL; Danesh A; Lopez G; Randall MP; Dent MH; Farra LM; Menghani N; Dymek M; Desai H; Hausler R; ; ; ; Auvil JG; Gerhard DS; Hakonarson H; Maxwell KN; Cole KA; Pugh TJ; Bosse KR; Khan J; Wei JS; Maris JM; Stewart DR; Diskin SJ
medRxiv; 2023 Jan; ():. PubMed ID: 36747619
[TBL] [Abstract][Full Text] [Related]
39. Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer.
Alba-Pavón P; Alaña L; Astigarraga I; Villate O
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497448
[TBL] [Abstract][Full Text] [Related]
40. Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations.
Pastorino F; Capasso M; Brignole C; Giglio S; Bensa V; Cantalupo S; Lasorsa VA; Tondo A; Mura R; Sementa AR; Garaventa A; Ponzoni M; Amoroso L
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
